Here are some common reasons why patients may consider switching from tirzepatide to semaglutide
Traveling across time zones: the special case Crossing multiple time zones creates a unique timing challenge
Baseline scan before starting, follow-up at 6-8 weeks, and final assessment at protocol completion enable accurate fat loss quantification
Expert Perspective To better understand these patterns, we asked Alessandro Grenci, Superintendent Pharmacist at Medino , for his view
However, there are certain criteria that healthcare providers typically consider when determining if Semaglutide is the right choice for a patient: Body Mass Index (BMI): Semaglutide is generally recommended for individuals with a BMI of 30 or higher (classified as obese) or a BMI of 27 or higher with at least one weight-related health condition, such as high blood pressure, type 2 diabetes, or high cholesterol